integrichain logo
  • Solutions
    • By Role
      • Finance
      • Market Access/Commercial
      • Operations
    • By Stage
      • Navigating Your First Launch
      • Managing In Line Products
      • Portfolio Growth & Expansion

    Solutions

    From the first launch to ongoing market access operational execution, IntegriChain solves some of the most complex and pressing challenges associated with drug commercialization. We deliver pharma’s only comprehensive data, consulting, and business process platform for market access departments, providing the strategy, data, applications, and infrastructure for therapy commercialization.

    Solutions overview

  • Products
    • Contracts & Pricing
      • Government Pricing
      • Rebate Management
      • Chargeback Management
      • Script Management
    • Gross-To-Net
      • GTN Forecasting
      • GTN Accruals
      • GTN Analytics
    • Platform
      • ICyte Platform
    • Channel
      • Inventory Analytics
      • Distribution Contract Management
      • Order Management
      • Channel Data Solutions
    • Patient Access
      • Patient Data Solutions
      • Patient Analytics

    Products

    IntegriChain delivers the pharmaceutical  industry’s largest and only data and business process platform for therapy commercialization and access. Manufacturers rely on our analytics, applications, and managed services  to power their operations and harness the value of their channel, patient and payer data.

    View all products

  • Services
    • Strategy Consulting
      • Product and Launch Strategy
      • Policy, Pricing & Reimbursement
      • Market Access & Payer Strategy
      • Provider & Pharmacy
      • Patient Access & Affordability
      • Distribution & Logistics
      • Business Data & Analytics
      • Finance & Gross-To Net Optimization
    • Operational Consulting
      • Roadmap to Launch
      • State Price Transparency Reporting
      • ICyte Benchmarks
      • Contracts & Pricing Consulting
      • Gross-to-Net Consulting
      • Channel & Patient Data Consulting
    • Solution Delivery
      • Master Data Integration
      • Platform Migrations

    Services

    IntegriChain provides a complete set of professional services for commercialization and market access execution–from life science strategy and operational consulting to implementation, integration, migrations, and analytics.

    Services overview

  • About Us
    • About Us
    • Our Leadership
    • Contact Us
    • Resources
    • Blog
    • News
    • Events

    About Us

    We help all stakeholders in the pharmaceutical industry drive access with our relentless focus on unifying all of the critical business functions for therapy commercialization and access – contracts & pricing, gross-to-net, channel, and patient services – to unlock strategic payer, provider, pharmacy and patient access insights.

    Learn more about our company

  • Careers
    • Careers Overview
    • Vision & Values
    • IntegriChainer Life in the US
    • IntegriChainer Life in Pune
    • Career Openings
    • Connect with Us

    Careers

    Learn more about joining our growing IntegriChain team of data scientists, market access experts, analysts, and consulting professionals – our culture, our purpose, our teams in the US and Pune. Check out our careers or keep in touch for future opportunities.

    Careers overview

  • Search
  • Let’s Talk
Integrichain Blog

Blog

Category:   All Blog Posts
  • All Blog Posts
  • Access Transformation
  • Channel
  • Contracts & Pricing
  • Corporate
  • Distribution
  • Government Pricing
  • Gross-to-Net
  • ICyte Platform
  • Launch Readiness
  • Managed Services
  • Market Access
  • Patient Access
  • Specialty Pharmacy

Buy-and-bill analysis of the last ~50 brands that launched with IntegriChain.

July 1, 2021

INF Second Read

You Might Also Like...

Contracts & Pricing Ben Fanelli Sarah Vo
September 27, 2023

Inflation Reduction Act Updates

4 Minute Read

Hospital hallway with medical icons overlaid, emphasizing the importance of Inflation Reduction Act guidance for pharmaceutical manufacturers

Gross-to-Net Brittany Honeycutt Aaron Light Haley Morgaylo Tom Travaglini
August 29, 2023

Improving Gross-to-Net Estimates through Better Channel Analytics Part 2

2 Minute Read

Integrichain

Building pharma’s data-driven commercialization platform – from strategy to operational excellence.

8 Penn Center
1628 JFK Boulevard
Philadelphia, PA 19103
609.806.5005

  • LinkedIn
  • RSS
  • Solutions
    • By Role
      • Finance
      • Market Access/Commercial
      • Operations
    • By Stage
      • Navigating Your First Launch
      • Managing In Line Products
      • Portfolio Growth & Expansion
  • Products
    • Contracts & Pricing
    • Gross-to-Net
    • Platform
    • Channel
    • Patient Access
  • Services
    • Strategy Consulting
    • Operational Consulting
    • Solution Delivery
  • Careers
    • Careers Overview
    • Vision & Values
    • IntegriChainer Life in the US
    • IntegriChainer Life in Pune
    • Career Openings
    • Connect with Us
  • Company
    • About Us
    • Our Leadership
    • Contact Us
    • Resources
    • Blog
    • News
    • Events
  • Privacy Policy
  • Terms & Conditions

© 2023 IntegriChain Incorporated. All Rights Reserved.

adapt analytics bars bell books magnify chart connections marker meds pills search computer paper webcast article blog ebook distribute hand payer heart market Asset 69 Asset 65 Asset 64 Asset 68 Asset 67 Asset 66 Asset 63 decrease expand builder close dart data demand increase index lock locked meter open order pharma pill plot prescription revenue scorecard service shake unlocked Asset 61 Asset 60 Asset 71 icon-distribution-distribution-contract-management icon-distribution-distribution-data-refinery icon-distribution-inventory-analytics icon-distribution-retail-analytics icon-patient-patient-data-refinery icon-patient-patient-services-analytics icon-patient-specialty-pharmacy-analytics icon-payer-340b-analytics icon-payer-analytics icon-payer-g2n icon-payer-government-pricing icon-payer-rebate-management Asset 1 hand hand hand hand hand hand hand hand hand hand hand paper article